IL17A and psoriasis: It has therefore been observed that lymphocytes and their cytokines, especially interferon (IFNγ) and interleukin 17 (IL-17), affect other cells, leading to chronic inflammation and characteristic symptoms, such as skin plaques in psoriasis or arthrosis and limited mobility in psoriatic arthritis.